| Otsuka Pharmaceutical (Switzerland) GmbH - Abilify 30 mg, Tabletten |
| 56209 | | 03 | | Abilify 30 mg | | Tabletten | | N05AX12 | | Aripiprazol | | 05.08.2004 | | |
|
| Composition |
| aripiprazolum 30 mg, lactosum monohydricum 186.54 mg, maydis amylum, cellulosum microcristallinum, hydroxypropylcellulosum, magnesii stearas, aqua purificata, E 172 (rubrum) pro compresso. |
| Packungsbestandteile |
| Comprimés | | | | | Principe actif | Concentr. |
|---|
| Aripiprazole | 30 mg |
| | BAG: Principe actif | Concentr. |
|---|
| Aripiprazole | 30 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| (Rubrum) pro Compresso | | | | Aqua Purificata | | | | Cellulosum Microcristallinum | | | | E 172 | | color. | | Hydroxypropylcellulosum | | | | Lactose Monohydrate | 186.54 mg | | | Magnesii Stearas | | | | Maydis Amylum | | |
| |
|
| numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 024 | 28 Comprimé(s) | 102.24 | 126.65 | B | LS | Non |
|
